V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240002174 | 240008413 | 1.67 | 10.2 | null | null | 2021-04-04 | IMATINIB | N | null | ANAGRELIDE | 100903268 |
| 240002178 | 240008414 | 1.72 | null | Curative (C) | 2021-03-27 | 2021-03-27 | DABRAFENIB | 02 | null | AML INTERIM GUIDELINES FLAG-IDA | 100118687 |
| 240002180 | 240008415 | 0 | 76.4 | 03 | null | 2021-02-23 | IBRUTINIB | null | N | CYCLOPHOSPHAMIDE + CYTARABINE + DOXORUBICIN + METHOTREXATE + RITUXIMAB + VINCRISTINE | 100463085 |
| 240002185 | 240008416 | 1.87 | null | Curative (C) | 2019-07-24 | 2019-07-24 | Alemtuz+Fludara+Melphalan RIC MUD | 02 | null | AML MYECHILD | 100201115 |
| 240002188 | 240008418 | 1.67 | 89.2 | null | null | 2019-10-30 | CVP R | null | null | AML MYECHILD 01 HD ARAC | 100775225 |
| 240002189 | 240008419 | 1.81 | 80.8 | null | 2020-03-08 | 2020-03-17 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | 02 | null | ALL UKALL2011 STD INT MAINT A | 100197632 |
| 240002194 | 240008420 | 1.6 | 84.4 | Curative (C) | null | 2020-05-25 | BUSULFAN | null | null | DA | 100164261 |
| 240002197 | 240008421 | 1.72 | 97 | 03 | null | 2022-05-23 | null | N | null | AML MYECHILD 01 IT CYT | 101344732 |
| 240002199 | 240008422 | 1.68 | 60 | null | null | 2021-03-16 | null | null | null | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 101817798 |
| 240002204 | 240008423 | 1.78 | 93.8 | 03 | 2019-04-03 | 2019-04-13 | Cladribine (subcut) 5 days | N | N | IBRUTINIB | 101625150 |
| 240002206 | 240008424 | 1.83 | 94.4 | null | 2020-05-27 | 2020-05-27 | FLAIR trial | 02 | null | AML MYECHILD 01 IT CYT | 101859904 |
| 240002216 | 240008426 | 1.54 | 128.6 | null | 2020-08-24 | 2020-08-24 | NIVOLUMAB | 02 | null | CYTARABINE + DAUNORUBICIN | 100326439 |
| 240002218 | 240008427 | 1.68 | 96.4 | null | null | 2017-03-05 | null | null | null | VINBLASTINE | 101416658 |
| 240002222 | 240008428 | 1.64 | 105 | null | null | 2021-12-20 | AML16 DA 3+10 | null | null | METHOTREXATE INTRATHECAL | 101586362 |
| 240002224 | 240008429 | null | 74.7 | null | null | 2020-02-23 | AML MyeChild 01 A Mitozantrone/Cytarabine | null | null | TRIPLE INTRATHECAL | 100606828 |
| 240002229 | 240008431 | 0 | 20.8 | null | null | 2021-01-10 | DA 3 + 10 | null | null | LCHIV SL-IT | 100470580 |
| 240002234 | 240008432 | 1.63 | 60 | Curative (C) | null | 2019-11-07 | Venetoclax | null | null | IPILIMUMAB + NIVOLUMAB | 101496504 |
| 240002251 | 240008437 | 0 | 40.8 | null | null | 2017-04-10 | Cytarabine High Dose | null | null | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN | 100816566 |
| 240002254 | 240008439 | 1.76 | 89.4 | 03 | null | 2021-03-01 | CODOX M | null | null | AML INTERIM GUIDELINES FLAG-IDA | 100373241 |
| 240002256 | 240008440 | 1.6 | 73.5 | Curative (C) | null | 2020-03-29 | null | 2 | N | R IVAC | 101531033 |
| 240002261 | 240008443 | 0 | 33.4 | Curative (C) | 2020-02-05 | 2020-04-05 | null | 02 | N | MATRIX LYMPHOMA TRIAL | 100357336 |
| 240002262 | 240008444 | 1.63 | null | null | 2019-06-05 | 2019-06-12 | null | null | null | AML INTERIM GUIDELINES FLAG-IDA | 100911940 |
| 240002264 | 240008445 | 1.62 | 64 | null | 2020-08-19 | 2020-09-01 | BUSULFAN + CYCLO | N | null | RUXOLITINIB | 100508934 |
| 240002273 | 240008447 | 1.7 | 79.1 | Curative (C) | 2017-05-13 | 2017-05-28 | IMATINIB | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE | 101781462 |
| 240002277 | 240008448 | 1.76 | 100.4 | null | 2019-02-17 | 2019-02-17 | LEAM | 02 | null | CYTARABINE + METHOTREXATE + RITUXIMAB | 100495092 |
| 240002282 | 240008451 | 1.82 | 43 | Palliative (P) | 2019-09-01 | 2019-09-12 | null | null | N | BENDAMUSTINE + POLATUZUMAB VEDOTIN + RITUXIMAB | 101256721 |
| 240002285 | 240008452 | 0 | 34 | 03 | 2018-11-17 | 2018-12-12 | ICE-R | 2 | N | LENALIDOMIDE | 101013080 |
| 240002292 | 240008454 | 1.68 | null | Curative (C) | 2019-07-09 | 2019-07-18 | R GCVP | N | N | RUXOLITINIB | 100628748 |
| 240002298 | 240008456 | 1.68 | 50.7 | 03 | 2021-07-23 | 2021-07-23 | BUSULFAN | 02 | N | DABRAFENIB | 100054492 |
| 240002301 | 240008457 | 1.12 | 80 | Curative (C) | 2019-08-27 | 2019-08-31 | R IVAC | N | N | RUXOLITINIB | 100615797 |
| 240002306 | 240008458 | 1.76 | 29.25 | null | 2019-08-18 | 2019-08-18 | FLAG + Idarubicin | 02 | Y | RUXOLITINIB | 101002930 |
| 240002309 | 240008459 | 1.72 | 69 | 03 | null | 2020-10-02 | null | null | N | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 101022921 |
| 240002310 | 240008460 | 1.86 | 99.2 | null | null | 2019-04-03 | null | 02 | null | TRANSPLANT CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 100045573 |
| 240002315 | 240008462 | 1.46 | 72.6 | null | 2019-12-19 | 2019-12-22 | Triple / Double Intrathecal Therapy | 02 | null | CYTARABINE HIGH DOSE | 100052435 |
| 240002316 | 240008463 | 1.48 | null | Curative (C) | 2018-04-19 | 2018-11-30 | R CODOX-M/ R IVAC | 02 | N | CNS HGG TEMOZOLOMIDE MAINTENANCE | 100992913 |
| 240002318 | 240008464 | 1.64 | 75 | Curative (C) | 2020-05-06 | 2020-05-06 | CARFILZOMIB + LENALIDOMIDE | 01 | N | ANTI-THYMOCYTE GLOBULIN + BUSULFAN + FLUDARABINE | 100966846 |
| 240002319 | 240008465 | 1.7 | 78.5 | Curative (C) | 2021-10-24 | 2021-10-24 | FLAIR trial | 02 | null | CYTARABINE + ETOPOSIDE + LOMUSTINE + MELPHALAN | 101744469 |
| 240002323 | 240008466 | null | null | Curative (C) | null | 2020-08-03 | Rituximab + Venetoclax | null | null | CISPLATIN + GEMCITABINE | 101286007 |
| 240002331 | 240008468 | 1.77 | 23.9 | null | 2017-05-23 | 2017-07-06 | null | 02 | null | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 101376472 |
| 240002341 | 240008471 | 1.7 | 95.1 | Curative (C) | 2019-03-10 | 2019-03-10 | Cyclophosphamide High Dose | 02 | null | CYTARABINE + DAUNORUBICIN | 100552467 |
| 240002344 | 240008472 | 1.83 | 73.7 | Palliative (P) | 2019-04-12 | 2020-05-30 | null | 02 | N | RUXOLITINIB | 101583614 |
| 240002345 | 240008473 | 1.57 | 83.1 | Curative (C) | 2020-11-20 | 2020-11-25 | null | 02 | null | NOT MATCHED | 100710683 |
| 240002348 | 240008474 | 1.53 | 74.4 | 03 | 2017-09-14 | 2017-09-15 | ALL UKALL2011 Del Int A Pt1 (PAsp) | 02 | N | RUXOLITINIB | 101476143 |
| 240002350 | 240008475 | 1.62 | 12.06 | 03 | 2019-09-20 | 2019-09-26 | IBRUTINIB | 02 | null | BUSULFAN | 101108568 |
| 240002352 | 240008477 | 1.86 | 18.4 | null | 2018-12-22 | 2018-12-27 | FLAG + Idarubicin | 02 | null | CYTARABINE HIGH DOSE | 101831215 |
| 240002354 | 240008478 | 1.6 | 106 | null | null | 2021-02-23 | AML MyeChild 01 Triple IT | N | null | METHOTREXATE INTRATHECAL | 101399423 |
| 240002365 | 240008480 | 1.74 | 72.8 | null | 2016-07-24 | 2016-08-03 | UKALL14- Maintenance | 02 | null | FLAG + IDARUBICIN | 101217456 |
| 240002367 | 240008481 | 1.77 | 83.7 | Palliative (P) | 2021-12-01 | 2021-12-20 | AML MyeChild 01 HD AraC | N | null | VENETOCLAX | 101074915 |
| 240002369 | 240008482 | 1.75 | 59.7 | 03 | null | 2020-10-22 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | null | N | ALL UKALL2011 DEL INT C | 100088320 |
| 240002371 | 240008483 | 1.65 | 59.6 | Curative (C) | 2016-06-12 | 2016-06-13 | CHOP - 21 days | N | N | R-EPOCH | 100978389 |